- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03942393
Noise in the Intensive Care Care Unit and Its Influence on Cortical Arousals and Sleep Phases
Noise in the Intensive Care Care Unit and Its Influence on Cortical Arousals: a Prospective Cohort Study
Study Overview
Status
Conditions
Detailed Description
This is a prospective observational study conducted from April 2016 to October 2017 in the general-neurologic ICU In a university-affiliated hospital serving a population of 1 million habitant in the north-east of Italy. Patients were considered eligible if they were older than 18 and remained in the ICU for at least 24 hours. Patients with anamnestic severe dementia, severely decreased mental state defined as Richmond Agitation-Sedation Scale (RASS) lower than -3, and language barrier were excluded. Patients coming from other hospitals were excluded, because they might have been treated with long-lasting sleep or sedative drugs, which could deeply modify sleep quality. Patients needing continuous infusion of sedative drugs were also excluded since this could interfere with the interpretation of PSG data. Finally, patients with frontal wounds, brain lesions in the frontal lobes, external ventricular drainage and noninvasive mechanical ventilation were excluded because of the impossibility to position the PSG device.
The study was conducted in accordance with the Declaration of Helsinki and was approved by the local Ethics Committee of Brescia (NP 23332). Patients' informed consent was waived due to the lack of definition of a legal representative of temporarily incapacitated adult patients in the Italian legislation. The informed consent was obtained from the surviving patients as soon as they regained their mental competency. Family members received detailed information on the study scope and protocol. .
Sleep was monitored using a simplified PSG, Sleep Profiler (Advanced Brain Monitoring) with the device placed by the nursing staff, from 10:00 pm to 7:00 am, for a minimum of one night to a maximum of five consecutive nights . In case of occurrence of any of the exclusion criteria, such as positioning of external ventricular drainage, the PSG monitoring was interrupted. The authors collected data on age, sex, the Simplified Acute Physiology Score (SAPS II) reason for ICU admission, length of ICU stay, and presence of delirium, assessed three times daily using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Any administration of drugs that could influence sleep were also recorded, including benzodiazepine as anxiolytics, opioids, dexmedetomidine, zolpidem, and melatonin.
The Sleep Profiler consists of a band with three channels for EEG, one channel for the electromyography of the masseter muscle (a touch proof connector with two electrodes), a plethysmography for heart rate, a microphone to register both ICU noise and patient snoring, and a 3D accelerometer to record head movements23. The registered parameters were then analyzed by a software that identifies sleep stages and Cortical Arousals (CA), and a report was generated for each night.
The authors analyzed the association of nocturnal noise, defined as the percentage of Total Sleep Time (TST) during which noise exceeds 40 decibel (dB), with duration of Rapid Eye Movement (REM )and Slow Wave Sleep (SWS) phases, expressed as a percentage of TST, and number of CAs.
STATISTICAL ANALYSIS Characteristics of the study population were summarized as number (percentage) for binary variables, and as mean (standard deviation, SD) or median (interquartile range, IQR), as appropriate, for continuous variables.
The study outcomes were duration of the REM and SWS stages and number of CAs, all analyzed as binary variables: REM: 0% or > 0% of the TST; SWS: ≤9% or > 9% of TST (threshold previously used in the literature24,25); CAs: ≤43 or >43 CAs per hour (threshold corresponding to the median value in our ICU, in the absence of information from the literature).
The association of noise with REM, SWS and CAs was analyzed using mixed-effect logistic regression models for repeated measures (measurements over nights for each patient), adjusting for SAPS II, age and sex as potential confounders. A sensitivity analysis were also performed in which further adjustment for the administration of drugs influencing sleep were added. Results are presented as odds ratio (OR) and 95% confidence interval (95% CI).
All statistical analyses were performed using STATA (Stata Corp, Texas, USA).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Brescia, Italy, 25123
- Spedali Civili, Anestesia e Rianimazione 2
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- older than 18
- recovered in ICU
- remained in the ICU for at least 24 hours.
Exclusion Criteria:
- patients with anamnestic severe dementia
- patients with severely decreased mental state (defined as Richmond Agitation-Sedation Scale, RASS, lower than -3)
- presence of language barrier
- patients coming from other hospitals
- patients needing continuous infusion of sedative drugs
- patients with frontal wounds, brain lesions in the frontal lobes, external ventricular drainage and noninvasive mechanical ventilation were excluded because of the impossibility to position the PSG device
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of cortical arousals per hour
Time Frame: Up to 5 consecutive nights from 10:00 pm to 7:00 am
|
analyzed as binary variables:< 43 or > 43per hour regression
|
Up to 5 consecutive nights from 10:00 pm to 7:00 am
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
presence of REM phases
Time Frame: Up to 5 consecutive nights from 10:00 pm to 7:00 am
|
analyzed as binary variables:0% or > 0% of Total sleep time
|
Up to 5 consecutive nights from 10:00 pm to 7:00 am
|
|
Duration of SWS phases
Time Frame: Up to 5 consecutive nights from 10:00 pm to 7:00 am
|
analyzed as binary variables: < 9% or > 9% of Total Sleep Time
|
Up to 5 consecutive nights from 10:00 pm to 7:00 am
|
Collaborators and Investigators
Investigators
- Principal Investigator: ELISA SEGHELINI, II Servizio Rianimazione,, Spedali Civili Brescia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NP23332
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Phase Rhythm Disturbance
-
New York State Psychiatric InstituteCompletedSleep Deprivation | Sleep Phase Rhythm DisturbanceUnited States
-
Zhuan ZhangNot yet recruitingCircadian Rhythm | Postoperative Sleep DisturbanceChina
-
Brigham and Women's HospitalStanford UniversityCompletedSleep Wake Disorders | Sleep Disorder | Sleep Disorders, Circadian Rhythm | Circadian Rhythm Disorders | Circadian Rhythm Sleep Disorder | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase SyndromeUnited States
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityTerminatedSleep Disorders, Intrinsic | Sleep Wake Disorders | Sleep Disorders, Circadian Rhythm | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase Syndrome | Shift-Work Sleep Disorder | Delayed Sleep Phase | Non-24 Hour Sleep-Wake Disorder | Advanced Sleep Phase Syndrome | Advanced Sleep Phase | Irregular... and other conditionsUnited States
-
Brigham and Women's HospitalTerminatedSleep Disorders, Intrinsic | Sleep Disorders, Circadian Rhythm | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase Syndrome | Shift-Work Sleep Disorder | Delayed Sleep Phase | Non-24 Hour Sleep-Wake Disorder | Advanced Sleep Phase Syndrome | Advanced Sleep Phase | Irregular Sleep-Wake Syndrome | Shift...United States
-
University of BergenCompletedSleep | Circadian Rhythm Sleep Disorder, Delayed Sleep PhaseNorway
-
University of HelsinkiAcademy of FinlandUnknownSleep Disorder Circadian Rhythm, Delayed Sleep Phase TypeFinland
-
Ataturk UniversityCompletedSleep Disturbance | Intensive Care Unit Patients | Circadian Rhythm Sleep DisordersTurkey (Türkiye)
-
University of Colorado, BoulderNational Heart, Lung, and Blood Institute (NHLBI); Northwestern UniversityRecruitingDelayed Sleep Phase Syndrome | Delayed Sleep PhaseUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedSleep | Sleep Disturbance | Anesthesia | Sleep Disorders, Circadian Rhythm | Circadian Rhythm Sleep Disorder | Circadian Rhythm Disorder Caused by Drug | Circadian Rhythm Sleep Disorder, Jet Lag Type | Jet LagNetherlands